The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain for adults.

The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...

“A new non-opioid analgesic therapeutic class for acute pain offers an opportunity to mitigate certain risks associated with using an opioid for pain and provides patients with another treatment ...

The drug represents a new pathway to treating people with pain due to surgeries or traumatic injuries, avoiding the addictive risks of opioids.

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

The below narcotic medications are FDA-approved for use in animals: Millions of dogs are prescribed opioids every year. But keep in mind that opioids are the strongest pain medications available ...

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...

The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...

This is the first class of non-opioid pain medication approved to treat moderate to severe acute pain approved by the FDA in more than 20 years. MORE: Opioids are no better than a placebo for back ...

This is the first class of non-opioid pain medication approved to treat moderate to severe acute pain approved by the FDA in more than 20 years. “Today’s approval is an important public health ...